Bristol Myers Squibb Balance Sheet

BMY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.

Bristol Myers Squibb had $90.0B in total assets and $18.5B in shareholders' equity as of FY2025. Total debt was $44.8B against $10.2B in cash, resulting in $34.6B net debt.

Based on SEC 10-K filings.

Key Data Points

High Piotroski F-Score: 8/9 (strong financial health signals)
Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
High earnings quality (cash-backed earnings)
Strong return on equity: 32.6%

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Cash & Equivalents	$10.2B	$10.3B	$11.5B	$9.1B	$14.0B	$14.5B	$7.3B	$5.4B	$3.9B	$5.6B	$3.6B	$5.6B	$5.8B	$5.0B	$5.8B
Accounts Receivable	$9.6B	$9.0B	$8.9B	$8.2B	$8.0B	$7.2B	$6.5B	$4.6B	$4.3B	$3.8B	$2.9B	$2.1B	$1.7B	$1.7B	$2.3B
Inventory	$2.7B	$2.6B	$2.7B	$2.3B	$2.1B	$2.1B	$4.3B	$1.2B	$1.2B	$1.2B	$1.2B	$1.6B	$1.5B	$1.7B	$1.4B
Current Assets	$29.4B	$29.8B	$31.8B	$27.3B	$33.3B	$30.2B	$29.4B	$17.2B	$14.9B	$13.7B	$10.4B	$14.6B	$18.9B	$9.5B	$15.3B
PP&E (Net)	$7.5B	$7.1B	$6.6B	$6.3B	$6.0B	$5.9B	$6.3B	$5.0B	$5.0B	$5.0B	$4.4B	$4.4B	$4.6B	$5.3B	$4.5B
Goodwill	$21.8B	$21.7B	$21.2B	$21.1B	$20.5B	$20.5B	$22.5B	$6.5B	$6.9B	$6.9B	$6.9B	$7.0B	$7.1B	$5.6B	$5.6B
Total Assets	$90.0B	$92.6B	$95.2B	$96.8B	$109.3B	$118.5B	$34.8B	$33.1B	$32.9B	$31.9B	$33.6B	$33.4B	$36.0B	$32.4B	$30.9B
Current Liabilities	$23.4B	$23.8B	$22.3B	$21.9B	$21.9B	$19.1B	$18.3B	$10.7B	$9.6B	$8.8B	$8.0B	$8.5B	$12.4B	$8.3B	$7.8B
Total Debt	$44.8B	$49.4B	$39.5B	$39.0B	$44.4B	$50.3B	$5.6B	$5.8B	$7.2B	$5.7B	$6.5B	$7.4B	$7.2B	$5.3B	$5.3B
Shareholders' Equity	$18.5B	$16.3B	$29.4B	$31.1B	$35.9B	$37.8B	$51.6B	$14.0B	$11.7B	$16.2B	$14.3B	$14.9B	$15.2B	$13.6B	$16.0B

Other Financial Statements

Income Statement Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Bristol Myers Squibb Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Cash & Equivalents

$10.2B

$10.3B

$11.5B

$9.1B

$14.0B

$14.5B

$7.3B

$5.4B

$3.9B

$5.6B

$3.6B

$5.6B

$5.8B

$5.0B

$5.8B

Accounts Receivable

$9.6B

$9.0B

$8.9B

$8.2B

$8.0B

$7.2B

$6.5B

$4.6B

$4.3B

$3.8B

$2.9B

$2.1B

$1.7B

$2.3B

Inventory

$2.7B

$2.6B

$2.7B

$2.3B

$2.1B

$4.3B

$1.2B

$1.6B

$1.5B

$1.7B

$1.4B

Current Assets

$29.4B

$29.8B

$31.8B

$27.3B

$33.3B

$30.2B

$29.4B

$17.2B

$14.9B

$13.7B

$10.4B

$14.6B

$18.9B

$9.5B

$15.3B

PP&E (Net)

$7.5B

$7.1B

$6.6B

$6.3B

$6.0B

$5.9B

$6.3B

$5.0B

$4.4B

$4.6B

$5.3B

$4.5B

Goodwill

$21.8B

$21.7B

$21.2B

$21.1B

$20.5B

$22.5B

$6.5B

$6.9B

$7.0B

$7.1B

$5.6B

Total Assets

$90.0B

$92.6B

$95.2B

$96.8B

$109.3B

$118.5B

$34.8B

$33.1B

$32.9B

$31.9B

$33.6B

$33.4B

$36.0B

$32.4B

$30.9B

Current Liabilities

$23.4B

$23.8B

$22.3B

$21.9B

$19.1B

$18.3B

$10.7B

$9.6B

$8.8B

$8.0B

$8.5B

$12.4B

$8.3B

$7.8B

Total Debt

$44.8B

$49.4B

$39.5B

$39.0B

$44.4B

$50.3B

$5.6B

$5.8B

$7.2B

$5.7B

$6.5B

$7.4B

$7.2B

$5.3B

Shareholders' Equity

$18.5B

$16.3B

$29.4B

$31.1B

$35.9B

$37.8B

$51.6B

$14.0B

$11.7B

$16.2B

$14.3B

$14.9B

$15.2B

$13.6B

$16.0B